Healthy Research Rewards
ResearchHub is incentivizing healthy research behavior. At this time, first authors of open access papers are eligible for rewards. Visit the publications tab to view your eligible publications.
Got it
HK
Homan Kang
Author with expertise in Positron Emission Tomography Imaging in Oncology
Achievements
Cited Author
Open Access Advocate
Key Stats
Upvotes received:
0
Publications:
3
(67% Open Access)
Cited by:
322
h-index:
36
/
i10-index:
75
Reputation
Biology
< 1%
Chemistry
< 1%
Economics
< 1%
Show more
How is this calculated?
Publications
0

Aptamer-Conjugated Multi-Quantum Dot-Embedded Silica Nanoparticles for Lateral Flow Immunoassay

Kwanghee Yoo et al.Jan 16, 2025
Lateral flow immunoassays (LFIAs) are widely used for their low cost, simplicity, and rapid results; however, enhancing their reliability requires the meticulous selection of ligands and nanoparticles (NPs). SiO2@QD@SiO2 (QD2) nanoparticles, which consist of quantum dots (QDs) embedded in a silica (SiO2) core and surrounded by an outer SiO2 shell, exhibit significantly higher fluorescence intensity (FI) compared to single QDs. In this study, we prepared QD2@PEG@Aptamer, an aptamer conjugated with QD2 using succinimidyl-[(N-maleimidopropionamido)-hexaethyleneglycol]ester, which is 130 times brighter than single QDs, for detecting carbohydrate antigen (CA) 19-9 through LFIA. For LFIA optimization, we determined the optimal conditions as a 1.0:2.0 × 10−2 ratio of polyethylene glycol (PEG) to aptamer by adjusting the amounts of PEG and aptamer, phosphate-buffered saline containing 0.5% Tween® 20 as a developing solution, and 0.15 μg NPs by setting the NP weight during development. Under these conditions, QD2@PEG@Aptamer selectively detected CA19-9, achieving a detection limit of 1.74 × 10−2 mg·mL−1. Moreover, FI remained stable for 10 days after detection. These results highlight the potential of QD2 and aptamer conjugation technology as a reliable and versatile sensing platform for various diagnostic applications.